(Q36556720)

14 August 2017

1 reference

title

Prevention programmes of progressive renal disease in developing nations (English)

1 reference

14 August 2017

1 reference

Igor Codreanu

1

0 references

Giuseppe Remuzzi

object named as

Giuseppe Remuzzi

series ordinal

5

0 references

Arrigo Schieppati

series ordinal

4

object named as

Arrigo Schieppati

1 reference

14 August 2017

Norberto Perico

2

1 reference

14 August 2017

Sanjib K Sharma

series ordinal

3

1 reference

14 August 2017

publication date

1 August 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

11

1 reference

14 August 2017

issue

4

1 reference

14 August 2017

page(s)

321-328

1 reference

Emerging epidemic of cardiovascular disease in developing countries

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00587.X

Mortality from smoking worldwide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00587.X

Overview: end-stage renal disease in the developing world.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00587.X

CADASIL: a monogenic condition causing stroke and subcortical vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00587.X

Regional variations in the incidence of end-stage renal failure in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00587.X

Nephrology in Latin America, with special emphasis on Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00587.X

End-stage renal disease in sub-Saharan and South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00587.X

End-stage renal disease in developing countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00587.X

Treatment of end-stage renal disease in central and eastern Europe: overview of current status and future needs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00587.X

Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00587.X

Long-term consequences of low birth weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00587.X

Relationship between weight at birth and the number and size of renal glomeruli in humans: a histomorphometric study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00587.X

Testing for microalbuminuria in 2002: barriers to implementing current guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00587.X

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00587.X

The cost-effectiveness of treating all patients with type 2 diabetes with angiotensin-converting enzyme inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00587.X

Screening to prevent renal failure in insulin dependent diabetic patients: an economic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00587.X

Screening for proteinuria in US adults: a cost-effectiveness analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00587.X

Ramipril prolongs life and is cost effective in chronic proteinuric nephropathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00587.X

Dialysis delayed is death prevented: a clinical perspective on the RENAAL study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00587.X

An economic evaluation of the Irbesartan in Diabetic Nephropathy Trial (IDNT) in a UK setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00587.X

Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00587.X

Prevalence of kidney damage in Australian adults: The AusDiab kidney study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00587.X

Taking a public health approach to the prevention of end-stage renal disease: the NKF Singapore Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00587.X

The okinawa screening program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00587.X

Prevention of chronic renal failure at the community level

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00587.X

Experience with a program for prevention of chronic renal failure in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00587.X

Angiotensin-converting-enzyme inhibition therapy in altitude polycythaemia: a prospective randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00587.X

Erythropoietin-resistant anaemia in a predialysis patient with Klinefelter syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00587.X

Prevention of renal failure: the Malaysian experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00587.X

Kidney disease among the Zuni Indians: the Zuni Kidney Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00587.X

Tracking ancient pathways to a modern epidemic: diabetic end-stage renal disease in Saskatchewan aboriginal people

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00587.X

Renal function and cardiovascular risk markers in a remote Australian Aboriginal community

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00587.X

The pharmaceutical industry as a medicines provider

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00587.X

The June 2003 Barry M. Brenner Comgan lecture. The future of renoprotection: frustration and promises.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00587.X

Strategies for national health care systems and centers in the emerging world: Central America and the Caribbean--the case of Cuba

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00587.X

A new dimension to the Barker hypothesis: Low birthweight and susceptibility to renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00587.X

Albuminuria as early test for vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00587.X

Renal epidemiology. The first clinical and epidemiological programme on renal disease in Bolivia: a model for prevention and early diagnosis of renal diseases in the developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00587.X

10.1111/J.1440-1797.2006.00587.X

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference